Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in Women at High Inherited Risk of Breast Cancer
NCT00285857Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Nov 2005
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lovastatin in breast cancer, sponsored by Stanford University. Primary endpoint: Change in the Incidence of Abnormal Breast Duct Cytology at 6 months. Started Nov 2005; status: terminated.
02
Drugs
lovastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00285857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285857.